Gene Editing Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts

The Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Gene Editing Market?
The market size for gene editing has seen substantial growth recently. It is projected to expand from $8.82 billion in 2024 to $10.34 billion in 2025, boasting a compound annual growth rate (CAGR) of 17.3%. The rise in the historical period can be credited to the discovery of crispr-cas9, progress in genetic sequencing, significant medical advancements, funding for scientific research, and the expansion of the biotechnology industry.

In the upcoming years, the gene editing market size is projected to experience swift acceleration. Its growth trajectory shows that it could reach $20.79 billion in 2029, with an impressively high compound annual growth rate (CAGR) of 19.1%. The expansion anticipated can be ascribed to the development of therapeutic applications, improvements in precision and efficiency, commercialization of gene therapy, advancements in agricultural applications, and progress in regenerative medicine. The forecast period will likely be marked by trends like multiplex editing techniques, innovations in base editing, gene drives and population modification, introduction of non-viral delivery systems, and advancements in disease modeling and drug discovery.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2486

What Are the Different Gene Editing Market Segments?
The gene editing market covered in this report is segmented -

1) By Technology: CRISPR, TALEN, ZFN
2) By Application: Animal Genetic Engineering, Plant Genetic Engineering, Cell Line Engineering
3) By End Users: Biotechnology, Pharmaceutical, Contract Research Organization

Subsegments:
1) By CRISPR: CRISPR-Cas9, CRISPR-Cas12, CRISPR-Cas13, CRISPR-based Gene Drives
2) By TALEN (Transcription Activator-Like Effector Nucleases): Custom TALENs, Commercial TALEN Kits
3) By ZFN (Zinc Finger Nucleases): Custom ZFNs, Commercial ZFN Kits

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2486&type=smp

What Are the Primary Drivers Shaping the Gene Editing Market?
The upswing in the gene editing market is driven by the rising incidence of transmittable diseases, which necessitates the use of gene editing methods for diagnosis and treatment. Transmittable illnesses are those caused by infectious agents like bacteria, viruses, or parasites that can spread from person to person, animals, or the environment. The use of gene editing technologies is growing and is being applied to create targeted strategies that can identify and battle disease-causing organisms at their genetic level. This enhances efforts at managing and preventing diseases. For example, the World Economic Forum, a non-governmental international organization based in Switzerland, reported a rise in infections such as influenza and respiratory syncytial virus (RSV) since the pandemic in 2023. According to them, there have been about 24 million influenza cases, 260,000 hospitalizations, and 16,000 deaths from the disease in the USA as of February 2023. Furthermore, the World Health Organization stated in 2022 that approximately 10.6 million individuals worldwide contracted tuberculosis, with 1.3 million deaths resulting from the disease. Consequently, the increase in transmittable diseases is stimulating the growth of the gene editing market.

Which Companies Are Leading in the Gene Editing Market?
Major companies operating in the gene editing market include AstraZeneca plc, Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare Life Sciences, Agilent Technologies Inc., Lonza Group AG, PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., CRISPR Therapeutics, Promega Corporation, GenScript USA Inc., Integrated DNA Technologies Inc., Intellia Therapeutics Inc., DNA Script Inc., Dharmacon Inc., Precision Biosciences Inc., Editas Medicine Inc., OriGene Technologies Inc., Tecan Group Ltd., Sangamo Therapeutics Inc., Horizon Discovery Group plc, Addgene Inc., New England Biolabs Inc., Cellectis SA, Recombinetics Inc., Allele Biotechnology LLC, Transposagen Biopharmaceuticals Inc., Bluebird Bio Inc., Regeneron Pharmaceuticals Inc., Amsbio LLC, Creative Biogene Inc., Synthego Corporation, Beam Therapeutics Inc., Caribou Biosciences Inc., Inscripta Inc., Mammoth Biosciences Inc., Sangon Biotech (Shanghai) Co. Ltd., ToolGen Inc., Mirus Bio LLC

What Are the Major Trends Shaping the Gene Editing Market?
Leading enterprises in the gene editing markets are prioritizing the introduction of groundbreaking technology in gene editing, such as a stratagem focused on particular cell-penetrating peptides, to acquire a competitive upper hand. This approach may also stimulate the growth of advanced cellular therapies for cancer and other diseases. For example, in April 2023, Penn Medicine, a key health system in the US with numerous hospitals under its purview, discovered that some viral protein fragments can facilitate their cellular entry can also deliver CRISPR-Cas gene editing molecules into cells and their genetic nuclei at an exceptionally high efficiency and minimal cellular toxicity. Experts anticipate this innovative technique will be particularly beneficial in modifying T cells and other patient-derived cells to create cell therapies. One potential application could be in the area of CAR T-cell therapy, which harnesses specially altered patient's immune cells to combat cancer. This fresh take on cellular genetic engineering foresees massive improvements in speed, efficiency, and a significant decrease in cellular toxicity in comparison to present methods.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

What Are the Top Revenue-Generating Geographies in the Gene Editing Market?
North America was the largest region in the gene editing market in 2024. Western Europe was the second largest region in the global gene editing market share. The regions covered in the gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Gene Editing Market?
2. What is the CAGR expected in the Gene Editing Market?
3. What Are the Key Innovations Transforming the Gene Editing Industry?
4. Which Region Is Leading the Gene Editing Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.